Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy

Smith DA, Bradshaw D, Mbisa JL, et al. Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy. J Viral Hepat [Internet]. 2021;28(9):1256-1264. https://doi.org/10.1111/jvh.13549

Publication Type:

Journal Article

Authors:

Smith, DA; Bradshaw, D; Mbisa, JL; et, al

Source:

J Viral Hepat, Volume 28, Issue 9, p.1256-1264 (2021)

URL:

https://doi.org/10.1111/jvh.13549

Keywords:

Direct-acting antivirals, hepatitis C virus, Resistance-Associated Substitutions, Retreatment

Cited On:

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/34003556/

Export Citation:
RIS Format
Top